4//SEC Filing
Griffin Deborah A 4
Accession 0001209191-20-014850
CIK 0000818686other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:12 AM ET
Size
5.9 KB
Accession
0001209191-20-014850
Insider Transaction Report
Form 4
Griffin Deborah A
Chief Accounting Officer
Transactions
- Award
Restricted Share Units
2020-02-28+21,459→ 21,459 total→ Ordinary Shares (21,459 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on February 28, 2020 with 5,364 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 5,367 vesting on February 28, 2024.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001719115
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:12 AM ET
- Size
- 5.9 KB